LGVN vs EVOK
Comparison between Longeveron Inc - Class A (LGVN, Company) and Evoke Pharma Inc (EVOK, Company).
Both LGVN and EVOK are from the Healthcare sector.
5-Year PerformanceEVOK has outperformed LGVN, delivering a return of -52.2% compared to -59.3%
LGVN vs EVOK - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
LGVN vs EVOK - Historical Returns
Returns include dividend reinvestment.
LGVN vs EVOK - Annual Returns (2013 - 2026)
Returns include dividend reinvestment.
| Year | LGVN | EVOK |
|---|---|---|
| 2026 | +31.97% | N/A |
| 2025 | -71.73% | +146.09% |
| 2024 | -86.89% | -64.24% |
| 2023 | -59.64% | -61.10% |
| 2022 | -73.37% | -62.30% |
| 2021 | +62.89% | -79.63% |
| 2020 | N/A | +61.25% |
| 2019 | N/A | -36.47% |
| 2018 | N/A | +5.53% |
| 2017 | N/A | +9.18% |
| 2016 | N/A | -38.04% |
| 2015 | N/A | -45.36% |
| 2014 | N/A | -23.48% |
| 2013 | N/A | -36.54% |
LGVN vs EVOK Drawdown Comparison
The maximum drawdown for LGVN was -99.89%, occurring on Mar 6, 2026. This drawdown has not yet recovered.
The maximum drawdown for EVOK was -99.90%, occurring on Apr 8, 2025. This drawdown has not yet recovered.
The current LGVN drawdown is -99.81%. The current EVOK drawdown is -99.45%.
| Rank | LGVN | EVOK |
|---|---|---|
| #1 | -99.89% Nov 24, 2021 - Mar 6, 2026 | -99.90% Oct 4, 2013 - Apr 8, 2025 |
| #2 | -65.44% Mar 11, 2021 - Nov 19, 2021 | -0.66% Sep 30, 2013 - Oct 3, 2013 |
| #3 | -38.94% Nov 22, 2021 - Nov 24, 2021 | -0.34% Sep 25, 2013 - Sep 27, 2013 |
| #4 | -17.98% Feb 16, 2021 - Feb 24, 2021 | N/A |
| #5 | -16.61% Mar 2, 2021 - Mar 11, 2021 | N/A |
| #6 | -3.79% Feb 24, 2021 - Feb 26, 2021 | N/A |
| #7 | -1.25% Feb 26, 2021 - Mar 2, 2021 | N/A |
Correlation
Correlation between LGVN and EVOK is 0.47 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks